Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genome-wide analysis of enhancer landscape in colorectal cancer subgroups (ChIP-seq)

ABSTRACT: Genome-wide analysis of enhancer landscape in colorectal cancer subgroups (ChIP-seq)

PROVIDER: PRJNA658517 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12491700_1.fastq.gz	Fastqsanger.gz
	SRR12491700_2.fastq.gz	Fastqsanger.gz
	SRR12491800_1.fastq.gz	Fastqsanger.gz
	SRR12491800_2.fastq.gz	Fastqsanger.gz
	SRR12491701_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 760

Similar Datasets

Genome-wide analysis of enhancer landscape in colorectal cancer subgroups

Project description:Genome-wide analysis of enhancer landscape in colorectal cancer subgroups

| PRJNA658515 | ENA

Genome-wide analysis of enhancer landscape in colorectal cancer subgroups (RNA-seq)

Project description:Genome-wide analysis of enhancer landscape in colorectal cancer subgroups (RNA-seq)

| PRJNA658001 | ENA

Genome-wide analysis of enhancer landscape in colorectal cancer subgroups (ChIP-seq)

Project description:Colorectal cancer (CRC) is a highly malignant solid tumor and causes millions of cancer related death worldwide. Here, using H3K27ac chromatin immunoprecipitation followed by sequencing (ChIP-seq) coupled with gene expression data (RNA-seq), we describe the active cis-regulatory landscape across more than seventy diverse CRC patient tissues, including tumor and native tissue. Analysis of the enhancers and super-enhancers with recurrently gained or lost activity revealed novel, clinically relevant insights into CRC biology. Computational reconstruction of core regulatory circuitry identified a master set of transcription factors which is responsible for tumorigenesis and the maintenance of normal intestinal function. Genomic studies have revealed four distinct consensus molecular subgroups (CMS) with divergent biology and clinical behavior and we reveal that differentially regulated enhancers and super-enhancers reinforced inter-subgroup heterogeneity. Our integrated analysis of enhancer elements in a large series of CRC patient paired samples reveals novel insights into cis-regulatory architecture, unrecognized dependencies, and cellular origins.

2021-08-26 | GSE156613 | GEO

Genome-wide analysis of enhancer landscape in colorectal cancer subgroups (RNA-seq)

2021-08-26 | GSE156451 | GEO

Super-enhancer landscape profiling in primary colorectal carcinoma

Project description:Purpose: Examine H3K27ac enhancer and super-enhancer landscape differences between primary colorectal carcinoma and adjacent normal mucosa towards the identification of novel downstream targets. Methods: H3K27ac ChIP-seq and RNA-seq were performed on fresh primary colorectal carcinoma samples and normal colonic mucosa, from human patient samples. Results: We identified 2026 total super-enhancers in our cohort, between primary colorectal and normal mucosa. We quantified differences in H3K27ac signal within this space, between tumor and normal, and identified putative downstream target genes through integration with sample matched RNA-seq using a positive linear correlation model to identifty putative target genes.

2022-08-03 | GSE166254 | GEO

Proteogenomic landscape of medulloblastoma subgroups

Project description:Proteogenomic landscape of medulloblastoma subgroups

| PRJNA420382 | ENA

Super-enhancer landscape profiling in primary colorectal carcinoma

Project description:Super-enhancer landscape profiling in primary colorectal carcinoma

| PRJNA699855 | ENA

Hi-ChIP dataset for epigenomics landscape of colorectal cancer

Project description:Enhancer aberrations are beginning to emerge as a key feature of colorectal cancers, however, we have limited understanding of epigenomic patterns that distinguish tumors and underlying heterogeneity between tumors. Here, using epigenomic profiling of colorectal tumors, adenomas and normal colon tissues, we identify unique pattern of regulatory elements in colorectal cancer, which could reliably distinguish tumors from normal colon specimens. We define shared and unique enhancer elements during colorectal cancer progression using normal adjacent colon, adenomas and adenocarcinomas. We validate the functional nature of tumor-specific enhancers for important oncogenes such as ASCL2 and Fzd10. NMF clustering identified 4 epigenetic (EPIC) subtypes in colorectal cancer, which mimics consensus molecular subtypes (CMS)1, with an advantage of introducing a novel epigenetically-identifiable subtype with poor prognosis and survival. Based on this correlation, we defined and validated a combination therapeutic strategy of enhancer-blocking BETi with pathway specific inhibitor for 3 CMS subtypes. In conclusion, by comprehensive characterization of chromatin state patterns in colorectal tumors, we define epigenomic patterns during tumor evolution, heterogeneity of enhancers among patients and a combination therapy strategy for CMS-subgroups.

2021-05-22 | GSE136629 | GEO

Proteogenomic landscape of medulloblastoma subgroups [SNP]

Project description:Proteogenomic landscape of medulloblastoma subgroups [SNP]

| PRJNA420381 | ENA

Proteogenomic landscape of medulloblastoma subgroups [methylation]

Project description:Proteogenomic landscape of medulloblastoma subgroups [methylation]

| PRJNA413673 | ENA